Communicated by Phillip D Chilibeck.
The effects of growth hormone (GH) treatment on linear growth and body composition have been studied extensively. Little is known about the GH effect on energy expenditure (EE). The aim of this study was to investigate the effects of GH treatment on EE in children, and to study whether the changes in EE can predict the height gain after 1 year.
Total EE (TEE), basal metabolic rate (BMR), and physical activity level (PAL) measurements before and after 6 weeks of GH treatment were performed in 18 prepubertal children (5 girls, 13 boys) born small for gestational age (n = 14) or with growth hormone deficiency (n = 4) who were eligible for GH treatment. TEE was measured with the doubly labelled water method, BMR was measured with an open-circuit ventilated hood system, PAL was assessed using an accelerometer for movement registration and calculated (PAL = TEE/BMR), activity related EE (AEE) was calculated [AEE = (0.9 × TEE) − BMR]. Height measurements at start and after 1 year of GH treatment were analysed. This is a 1-year longitudinal intervention study, without a control group for comparison.
BMR and TEE increased significantly (resp. 5% and 7%). Physical activity (counts/day), PAL, and AEE did not change. 11 out of 13 patients (85%) with an increased TEE after 6 weeks of GH treatment had a good first-year growth response (∆height SDS > 0.5).
GH treatment showed a positive effect on EE in prepubertal children after 6 weeks. No effect on physical activity was observed. The increase in TEE appeared to be valuable for the prediction of good first-year growth responders to GH treatment.
Adriaens MP, Schoffelen PF, Westerterp KR (2003) Intra-individual variation of basal metabolic rate and the influence of daily habitual physical activity before testing. Br J Nutr 90(2):419–423 CrossRef
Bang P, Ahmed SF, Argente J, Backeljauw P, Bettendorf M, Bona G, Coutant R, Rosenfeld RG, Walenkamp MJ, Savage MO (2012) Identification and management of poor response to growth-promoting therapy in children with short stature. Clin Endocrinol (Oxf) 77(2):169–181. https://doi.org/10.1111/j.1365-2265.2012.04420.x CrossRef
Black AE, Prentice AM, Coward WA (1986) Use of food quotients to predict respiratory quotients for the doubly-labelled water method of measuring energy expenditure. Hum Nutr Clin Nutr 40(5):381–391
Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM (1997) Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 82(8):2423–2428. https://doi.org/10.1210/jcem.82.8.4149
Carrel AL, Myers SE, Whitman BY, Allen DB (1999) Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader–Willi syndrome: a controlled study. J Pediatr 134(2):215–221 CrossRef
Cole TJ (1996) Some questions about how growth standards are used. Horm Res Pediatr 45:18–23
Gregory JW, Greene SA, Jung RT, Scrimgeour CM, Rennie MJ (1991) Changes in body composition and energy expenditure after six weeks’ growth hormone treatment. Arch Dis Child 66(5):598–602 CrossRef
Gregory JW, Greene SA, Jung RT, Scrimgeour CM, Rennie MJ (1993) Metabolic effects of growth hormone treatment: an early predictor of growth response? Arch Dis Child 68(2):205–209 CrossRef
Hassan HM, Kohno H, Kuromaru R, Honda S, Ueda K (1996) Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment. Acta Paediatr 85(8):899–901 CrossRef
Henry CJ (2005) Basal metabolic rate studies in humans: measurement and development of new equations. Public Health Nutr 8(7a):1133–1152 CrossRef
Hoos MB, Westerterp KR, Kuipers H, Schuwirth L, Gerver WJ (2004) Physical activity as measured by accelerometry in children receiving growth hormone. Acta Paediatr 93(10):1307–1311 CrossRef
Human energy requirements (2005) Scientific background papers from the Joint FAO/WHO/UNU Expert Consultation. October 17–24 (2001) Rome, Italy. Public Health Nutr 8(7a):929–1228
Jorgensen JO, Moller J, Alberti KG, Schmitz O, Christiansen JS, Orskov H, Moller N (1993) Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects. J Clin Endocrinol Metab 77(6):1589–1596. https://doi.org/10.1210/jcem.77.6.8263146
Jorgensen JO, Pedersen SB, Borglum J, Moller N, Schmitz O, Christiansen JS, Richelsen B (1994) Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: a double-blind placebo-controlled study. Metab Clin Exp 43(7):872–877 CrossRef
Khadilkar V, Ekbote V, Kajale N, Khadilkar A, Chiplonkar S, Kinare A (2014) Effect of one-year growth hormone therapy on body composition and cardio-metabolic risk in Indian children with growth hormone deficiency. Endocr Res 39(2):73–78. https://doi.org/10.3109/07435800.2013.828742 CrossRef
Lohman TG (1989) Assessment of body composition in children. Pediatr Exerc Sci 1(1):19–30 CrossRef
Moller J, Jorgensen JO, Moller N, Christiansen JS, Weeke J (1992a) Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. Metab Clin Exp 41(7):728–731 CrossRef
Moller N, Schmitz O, Joorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J (1992b) Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 74(5):1012–1019. https://doi.org/10.1210/jcem.74.5.1569148
Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P (1991) An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977–1981). Acta Paediatr Scand 80(8–9):756–762 CrossRef
Ranke (2003) Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). J Clin Endocrinol Metab 88:125–131 CrossRef
Ranke (2009) Predicting growth in response to growth hormone treatment. Growth Hormon IGF Res 19:1–11 CrossRef
Vaisman N, Zadik Z, Shamai Y, Franklin L, Dukhan R (1992) Changes in body composition of patients with subnormal spontaneous secretion of growth hormone, during the first year of treatment with growth hormone. Metab Clin Exp 41:483–486
Vaisman N, Zadik Z, Akivias A, Voet H, Katz I, Yair S, Ashkenazi A (1994) Changes in body composition, resting energy expenditure, and thermic effect of food in short children on growth hormone therapy. Metab Clin Exp 43(12):1543–1548 CrossRef
Walker JM, Bond SA, Voss LD, Betts PR, Wootton SA, Jackson AA (1990) Treatment of short normal children with growth hormone—a cautionary tale? Lancet 336(8727):1331–1334 CrossRef
Weir JB (1949) New methods for calculating metabolic rate with special reference to protein metabolism. Nutrition (Burbank, Los Angeles County, Calif) 6(3):213–221
Westerterp KR (1999a) Body composition, water turnover and energy turnover assessment with labelled water. Proc Nutr Soc 58(4):945–951 CrossRef
Westerterp KR (1999b) Physical activity assessment with accelerometers. Int J Obes Relat Metab Disord 23(Suppl 3):S45–S49 CrossRef
Westerterp KR, Wouters L, van Marken Lichtenbelt WD (1995) The Maastricht protocol for the measurement of body composition and energy expenditure with labeled water. Obes Res 3(Suppl 1):49–57 CrossRef
- Effect of growth hormone treatment on energy expenditure and its relation to first-year growth response in children
D. A. Schott
Angèle J. G. M. Gerver-Jansen
Luc J. I. Zimmermann
Willem-Jan M. Gerver
- Springer Berlin Heidelberg
Neu im Fachgebiet Arbeitsmedizin